Effects of five-day versus one-day infusion of iloprost on the peripheral microcirculation in patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 15, Issue 4, 1997, Pages 381-385

  Ceru', S ^a   Pancera, P ^a   Sansone, S ^a   Sfondrini, G ^a   Codella, O ^a   De Sandre, G ^a   Lechi, A ^a   Lunardi, C ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b POLICLINICO BORGO ROMA   (Italy)

Author keywords

Iloprost; Piezoelectric pletismography; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; ILOPROST; PROSTACYCLIN;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; DATA ANALYSIS; ELECTROCARDIOGRAM; FEMALE; FIBROSIS; HUMAN; MICROCIRCULATION; PIEZOELECTRICITY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ILOPROST; INFUSIONS, INTRAVENOUS; MICROCIRCULATION; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PLATELET AGGREGATION INHIBITORS; PLETHYSMOGRAPHY; SCLERODERMA, SYSTEMIC; VASODILATOR AGENTS;

EID: 0030840489     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. KAHALEH MB, OSBORN I, LEROY EC: Elevated levels of circulating platelet aggregates and beta-tromboglobulin in scleroderma. Ann Intern Med 1982; 96: 610-3.
2. REILLY IA, ROY L, FITZGERALD GA: Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J 1986; 292: 1037-9.
3. RODNAN RP, MYEROWITZ RL, JUSTH GO: Morphologic changes in digital arteries of progressive systemic sclerosis (scleroderma) and Raynaud's phenomenon. Medicine (Baltimore) 1980; 59: 393-408.
4. NORTON WL, NARDO JM: Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970; 73: 317-24.
5. YLITALO P, KAUKINEN S, SEPPALA E, et al.: Pharmacological effects of iloprost (ZK 36 374), a stable prostacyclin analogue, in man. Biomed Biochim Acta 1984; 42: 399-402.
6. KELLER J, KALTENECKER A, SCHRICKER KT, NEIDHART B, HORNSTEIN OP: Inhibition of platelet aggegation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma. Arch Dermatol Res 1985; 277: 323-5.
7. WATSON HR, BELCHER G: Retrospective comparison of iloprost with other treatments for secondary Raynaud's phenomenon. Ann Rheum Dis 1991; 50: 359-61.
8. TORLEY HI, MADHOK R, CAPELL HA et al.: A double blind, randomized, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis 1991; 50: 800-4.
9. WIGLEY FM, WISE RA, SEIBOLD JR, et al.: Intravenous iloprost infusion in patients with Raynaud's phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 1994; 120: 199-206.
10. BELCH JJF, CAPELL HA, COOKE ED, et al.: Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study. Ann Rheum Dis 1995; 54: 197-200.
11. YARDUMIAN DA, ISENBERG DA, RUSTIN M, et al.: Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue. Br J Rheumatol 1988; 27: 220-6.
12. MCHUGH NJ, CSUKA M, WATSON H, et al.: Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. Ann Rheum Dis 1988; 47: 42-7.
13. KYLE MV, BELCHER G, HAZLEMAN BL: Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon. J Rheumatol 1992; 19: 1403-6.
14. WIGLEY FM, SEIBOLD JR, WISE RA, MCCLOSKEY DA, DOLE WP: Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol 1992; 19: 1407-14.
15. SUMMER DS: Volume plethysmography in vascular disease: an overview. In: BERNSTEIN EF (Ed.): Vascular Diagnosis. St Louis, Mosby, 1993: 181-93.
16. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATIC ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
17. KINGMA K, WOLLERSHEIM H, THIEN T: Double blind, placebo-controlled study of intravenous prostacyclin on hemodynamics in severe Raynaud's phenomenon: the acute vasodilatory effect is not sustained. J Cardiovasc Pharmacol 1995; 26: 388-93.